glp 1 drugs pcos Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? | Journal of Endocrinological Investigation Taking a GLP-1 for PCOS

The psychosocial risk factors associated with large reductions in weight and weight regain overlap significantly with those linked to perimenopause

However, one study into the use of one of these medications, Mounjaro, found that approximately 500,000 people in the UK have used the drug privately for weight loss since 2023

Close behind, Trulicity (dulaglutide) from Eli Lilly maintains a strong foothold with over $7 billion in annual sales

Compliance with Ethics Guidelines The study strictly complied with the current personal data protection regulations and was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments

We will use this information as part of your personalized program plan

[DOI] [PubMed] [Google Scholar] 650.Asmar A., Asmar M., Simonsen L., Madsbad S., Holst J.J., Hartmann B